Estimation of threshold thickness of residual normal tissue in lung dysfunction detectable by dynamic chest radiography: A virtual imaging trial

Author:

Yamaguchi Shunya1,Tanaka Rie2,Matsumoto Isao3,Ohkura Noriyuki4,Segars William Paul5,Abadi Ehsan5,Samei Ehsan5

Affiliation:

1. Graduate School of Health Sciences Kanazawa University Kanazawa Ishikawa Japan

2. College of Medical, Pharmaceutical & Health Sciences Kanazawa University Kanazawa Ishikawa Japan

3. Department of Thoracic Surgery Kanazawa University Kanazawa Ishikawa Japan

4. Department of Respiratory Medicine Kanazawa University Hospital Kanazawa Ishikawa Japan

5. Carl E Ravin Advanced Imaging Labs, Department of Radiology Duke University Durham North Carolina USA

Abstract

AbstractBackgroundDynamic chest radiography (DCR) is a recently developed functional x‐ray imaging technique that detects pulmonary ventilation impairment as a decrease in changes in lung density during respiration. However, the diagnostic performance of DCR is uncertain owing to an insufficient number of clinical cases. One solution is virtual imaging trials (VITs), which is an emerging alternative method for efficiently evaluating medical imaging technology via computer simulation techniques.PurposeThis study aimed to estimate the typical threshold thickness of residual normal tissue below which the presence of emphysema may be detected by DCR via VITs using virtual patients with different physiques and a user‐defined ground truth.MethodsTwenty extended cardiac‐torso (XCAT) phantoms that exhibited changes in lung density during respiration were generated to simulate virtual patients. To simulate a locally collapsed lung, an air sphere was inserted into each lung regions in the phantom. The XCAT phantom was virtually projected using an x‐ray simulator. The respiratory changes in pixel value (ΔPV) were measured on the projected air spheres (simulated lesions) to calculate the percentage of decrease (ΔPV%) relative to ΔPVexp‐ins in the absence of an air sphere. The relationship between the amount of residual normal tissue and ΔPV% was fitted to a cubic approximation curve (hereafter, performance curve), and the threshold at which the ΔPV% began to decrease (normal‐tissuethre) was determined. The goodness of fit for each performance curve was evaluated according to the coefficient of determination (R2) and the 95% confidence interval derived from the standard errors between the measured and theoretical values corresponding to each performance curve. The ΔPV% was also visualized as a color scaling to validate the results of the VITs in both virtual and clinical patients.ResultsFor each lung region in all body sizes, the ΔPV% decreased as the amount of residual normal tissue decreased and could be defined as a function of the amount of residual normal tissue in front of and behind the simulated lesions with high R2 values. Meanwhile, the difference between the measured and theoretical values corresponding to each performance curve was only partially included in the 95% confidence interval. The normal‐tissuethre values were 146.0, 179.5, and 170.9 mm for the upper, middle, and lower lungs, respectively, which were demonstrated in virtual patients and one real patient, where the value of the residual normal tissue was less than that of normal‐tissuethre; any reduction in the residual normal tissue was reflected as a reduced ΔPV and depicted as a reduced color intensity.ConclusionsThe performance of DCR‐based pulmonary impairment assessment depends on the amount of residual normal tissue in front of and behind the lesion rather than on the lesion size. The performance curve can be defined as a function of the amount of residual normal tissue in each lung region with a specific threshold of normal tissue remaining where lesions become detectable, shown as a decrease in ΔPV. The results of VITs are expected to accelerate future clinical trials for DCR‐based pulmonary function assessment.

Publisher

Wiley

Reference36 articles.

1. World Health Organization (WHO).The top 10 causes of death. Accessed February 12 2024.https://www.who.int/news‐room/fact‐sheets/detail/the‐top‐10‐causes‐of‐death

2. WHO.WHO reveals leading causes of death and disability worldwide: 2000–2019. Accessed February 12 2024.https://www.who.int/news/item/09‐12‐2020‐who‐reveals‐leading‐causes‐of‐death‐and‐disability‐worldwide‐2000‐2019

3. WHO.Global excess deaths associated with COVID‐19 January 2020–December 2021. Accessed February 12 2024.https://www.who.int/data/stories/global‐excess‐deaths‐associated‐with‐covid‐19‐january‐2020‐december‐2021

4. This is what COPD looks like

5. Dynamic Quantitative Magnetic Resonance Imaging Assessment of Areas of the Lung During Free-Breathing of Patients with Chronic Obstructive Pulmonary Disease

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3